Dozens of renowned hospitals within Boston and the surrounding Northeast region depend on the Sidera Network for critical healthcare service needs. To add to the company’s achievements in the healthcare industry, Sidera Networks announced today that it is the chosen network solutions provider for Acetylon Pharmaceuticals, a research and developer of drugs to treat cancer, autoimmune and other diseases. The company opted for Sidera’s Internet Access Service to power its Boston headquarters facility, located in the developing Seaport district.
On the heels of Acetylon’s announcement regarding its recent completion of a $28 million Series B Preferred equity investment round of funding, the company required a reliable and secure bandwidth provider to meet its growing data needs. With deep roots in Massachusetts, particularly in the Boston metropolitan area, plus a robust network, Sidera was the right choice to meet Acetylon’s demanding requirements.
Acetylon chose Sidera for its reliable and secure communications network and high quality Internet Access Service, attributes that are imperative for the research and development industry.
“Sidera is proud to provide secure network solutions that enable high growth companies like Acetylon to focus on their mission,” adds Mike Sicoli, CEO of Sidera Networks. “With Sidera as a trusted partner, Acetylon can be confident that they’ll have the bandwidth and network performance they need to succeed, not just today but into the future as well.”
For more information about Sidera Networks, visit www.sidera.net or follow Sidera on twitter @sideranetworks.
Read full press release here: http://www.sidera.net/news/press-releases/sidera-networks-powers-acetylon-pharmaceutical%E2%80%99s-internet-infrastructure
